Symptomatic Aortic Stenosis Clinical Trial
Official title:
Women's INternational Transcatheter Aortic Valve Implantation Registry
The study will evaluate all female patients with severe aortic stenosis undergoing transcatheter valve implantation with commercially available valves and delivery systems.
WINTAVI is an international, multi-centre, prospective, observational registry. The purpose of this study is to collect 'real-world' data regarding the clinical utility of all commercially available Transcatheter Aortic Valve Implantation (TAVI) devices for percutaneous aortic valve implantation in female patients with severe Aortic Stenosis (AS) requiring treatment. Data collected in this study will provide additional information on the understanding of the safety and device performance in a 'real-world' setting and how to best treat patients with severe AS. This will include Quality of Life questionnaires (KCCQ). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03003650 -
ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort
|
N/A | |
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Active, not recruiting |
NCT04091048 -
Optimize PRO Study
|
||
Withdrawn |
NCT03247465 -
Image Fusion and Calcification Raising in Trans Aortic Valve Implantation
|
N/A | |
Completed |
NCT03143686 -
ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)
|
||
Active, not recruiting |
NCT05182307 -
DurAVR™ THV System: First-In-Human Study
|
N/A | |
Active, not recruiting |
NCT03466918 -
China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population
|
N/A | |
Completed |
NCT04331145 -
Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation
|
Phase 4 | |
Recruiting |
NCT02803294 -
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
|
Phase 4 | |
Completed |
NCT02536196 -
The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
|
N/A | |
Recruiting |
NCT04861805 -
Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System
|
N/A | |
Withdrawn |
NCT02088021 -
Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access
|
N/A | |
Terminated |
NCT02759237 -
The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS)
|
N/A | |
Recruiting |
NCT01794832 -
Severe Aortic Stenosis in Patients Referred for Valve Surgery
|
N/A | |
Completed |
NCT02424370 -
Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation
|
||
Completed |
NCT01493284 -
Portico TAVI Implant With Transfemoral Delivery System
|
N/A | |
Active, not recruiting |
NCT05712161 -
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
|
N/A | |
Completed |
NCT02664649 -
Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
|
Phase 3 | |
Completed |
NCT01487330 -
First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System
|
N/A | |
Active, not recruiting |
NCT04722250 -
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
|
N/A |